Key result
Current smoking linked to ~3-fold higher risk of major bleeding after STEMI vs never smoking.
Why the study?
Guidelines recommend the ARC-HBR criteria for bleeding risk assessment in STEMI, but whether additional risk factors exist and how confounders affect the original criteria remained to be clarified.
Does smoking status predict major bleeding complications after STEMI independently of established ARC-HBR criteria?
Cohort (n=1,548)
No
Does smoking status predict major bleeding complications after STEMI independently of established ARC-HBR criteria?
Current and former smoking are significant independent risk factors for major bleeding after STEMI, potentially identifying a substantial group of high bleeding risk patients missed by conventional ARC-HBR criteria.
Answers are grounded in this paper and cite their sources.
Smoking may identify high bleeding risk STEMI patients missed by ARC-HBR; leaves open incorporation into risk models pending validation.
BACKGROUND AND AIMS: The Academic Research Consortium for High Bleeding Risk criteria (ARC-HBR) are recommended by guidelines for bleeding risk assessment in ST-elevation myocardial infarction (STEMI). The aim of this study was to identify possible other risk factors and adjust the original ARC-HBR criteria for confounders. METHODS AND RESULTS: All consecutive STEMI patients managed in a Finnish tertiary hospital between 2016 and 2022 were identified using a database search. Data collection was done by reviewing electronic patient records. Bleeding risk was assessed according to the ARC-HBR criteria. The primary endpoint was non-access site bleeding academic research consortium (BARC) type 3 or 5 bleeding during 1-year follow-up. A total of 1548 STEMI patients were analysed. HBR criteria was fulfilled in 661 (42.7%). Multivariable competing risk analysis identified only 4 individual ARC-HBR criteria as independent risk factors for bleeding. Smoking status was identified as a novel bleeding risk factor. Current and former smokers had increased bleeding risk compared with never smokers [hazard ratio (HR) 3.01, 95% confidence interval (CI) 1.62-5.61 and HR 1.99, CI 1.19-3.34]. In those not meeting any ARC-HBR criteria, cumulative BARC 3 or 5 incidence of current smoking was 3.40% and intracranial haemorrhage (ICH) 1.36%. Thus, exceeding ARC-HBR definition for a major criterion. In the non-HBR group the prevalence of current smoking was 40.4% (n = 358). CONCLUSION: Current and former smoking predicts major bleeding complications after STEMI. Current smoking is highly prevalent among those classified as non-HBR according to the ARC-HBR criteria.
No takes yet. Share an insight, caveat, or question.
Kesti et al. (2024) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=1,548). Current smoking vs. Never smoking was evaluated on Non-access site BARC type 3 or 5 bleeding during 1-year follow-up (HR 3.01, 95% CI 1.62-5.61, p=<0.001). Current smoking was independently associated with a three-fold increased risk of major bleeding complications compared to never smoking after STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: